No evidence of serious cardiovascular, hepatic, or systemic adverse effects has been observed in available clinical data, distinguishing Melanotan I from less-selective melanocortin agonists
Because these medications are similar, the side effects are too, but the frequency can vary with dose and medication
However, despite some similarities, Tesamorelin and CJC-1295 have unique characteristics, benefits, and mechanisms of action that make each suited to specific goals
Advice for Weight Loss Seekers For those considering semaglutide and GLP-1 medications, its important to determine if they are suitable candidates
Appropriate reasons to discuss discontinuation include achieving your weight loss goals and wanting to attempt weight maintenance without medication, experiencing intolerable side effects that don't improve with dose adjustment or supportive management, financial constraints that make continued treatment unsustainable, planning pregnancy (semaglutide is not recommended during pregnancy and should be discontinued at least two months before conception), or developing contraindications to continued use
doi: 10.1016/j.pharep.2018.11.001 26 PhillipsAClementsJN